← Eichor
Study identifier: NCT05446376 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective Endocarditis

Condition: Infective Endocarditis  ·  Sponsor: University Hospital, Bordeaux

PhasePhase 2
Planned participants40
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

CiGal-EI-TEP is an exploratory study that aim to assess the diagnostic performance of 68Ga Positron emission tomography (PET) / Computed Tomography (CT) for the diagnosis of prosthetic valve infective endocarditis in comparison with the final diagnosis established according to the ESC 2023 criteria, after 3 months of follow-up, by a panel of experts.

This description comes directly from the study's public registry record.

Talk to the study team

Carine GREIB, MD  ·  (0)5 57 65 64 83  ·  carine.greib@chu-bordeaux.fr

Sandrine FOUCHET  ·  sandrine.fouchet@chu-bordeaux.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU de BordeauxBordeaux, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05446376